Takeda Pharmaceuticals International, Inc.

MA · United States · Reporting entity ID 100000000336

Total reported 2019–2025

$1.43M

#1,172 of 2,960 reporting companies — 0% of all reported industry payments

$411K in general payments across 72 records, plus $1.01M in research funding across 24 records.

How it breaks down

General payments $410,557

Research funding $1,014,888

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.